PSN Urges Tinubu: Shut Open Drug Markets in Nigeria

• The Pharmaceutical Society of Nigeria (PSN) has urged President Bola Tinubu to close open drug markets across the country.
• The PSN called for pharmaceutical insecurity to be declared a national security threat.
• The organization warned that diverted controlled medicines, such as tramadol, are fueling terrorism and violent crimes.
• The PSN highlighted a direct link between unregulated drug markets and banditry in Nigeria.
• The society also commended the NLC, TUC, and JOHESU for their work on 19 months' arrears and CONHESS adjustment.

The organization explicitly warned that diverted controlled medicines, including substances like tramadol, are actively contributing to and fueling terrorism and various violent crimes across the country.

The Pharmaceutical Society of Nigeria (PSN) has recently issued a strong appeal to President Bola Tinubu, urging his administration to take decisive action regarding the widespread presence of open drug markets throughout Nigeria. This call specifically advocates for the closure of these unregulated distribution points, which the PSN identifies as a significant contributor to the nation's pharmaceutical insecurity.

The professional body underscored the critical link between the uncontrolled proliferation of these markets and a range of serious societal challenges. Their warning highlights that the current state of drug distribution poses a direct threat to public health and safety, necessitating immediate intervention from the highest levels of government.

The PSN's recommendations are part of a broader strategy to enhance drug market regulation in Nigeria, aiming to curb the availability of illicit and diverted pharmaceutical products. The expectation is that President Tinubu's administration will consider these proposals as it shapes its drug policy and enforcement priorities.

A central tenet of the Pharmaceutical Society of Nigeria's plea is the formal declaration of pharmaceutical insecurity as a national security threat. This designation would elevate the issue to a priority level, allowing for more comprehensive and coordinated efforts to tackle the challenges posed by unregulated drug supply chains.

The organization explicitly warned that diverted controlled medicines, including substances like tramadol, are actively contributing to and fueling terrorism and various violent crimes across the country. This direct connection between pharmaceutical products and criminal activities underscores the severe implications of a compromised drug supply system, linking it directly to the problem of controlled medicines banditry in Nigeria.

By framing pharmaceutical insecurity in this manner, the PSN aims to draw attention to the profound impact it has beyond public health, extending into the realm of national stability and security. Addressing this issue, therefore, becomes not just a matter of healthcare policy but a crucial component of the nation's overall security strategy.

Beyond their urgent recommendations concerning drug markets and national security, the Pharmaceutical Society of Nigeria also took the opportunity to commend several key labor organizations. The PSN specifically lauded the efforts of the Nigeria Labour Congress (NLC), the Trade Union Congress (TUC), and the Joint Health Sector Unions (JOHESU).

This commendation was extended in recognition of their successful advocacy regarding the payment of 19 months' worth of arrears and the adjustment of the Consolidated Health Salary Structure (CONHESS). This acknowledgement highlights the PSN's engagement with broader labor and welfare issues affecting healthcare professionals within the country, even as it champions critical reforms in drug regulation.

Lawyers and compliance officers should monitor potential legislative or executive actions by the Tinubu administration regarding the regulation and closure of open drug markets in Nigeria. This could lead to new enforcement policies, supply chain compliance requirements for pharmaceutical companies, and increased scrutiny on the distribution of controlled substances, impacting clients in the healthcare and pharmaceutical sectors.

Source: Original reporting via Vanguard News